How Does the Additional Benefit Extend of Orphan Drugs Impact Price Negotiations in the German Outpatient Sector?

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1462
https://www.valueinhealthjournal.com/article/S1098-3015(16)32828-5/fulltext
Title : How Does the Additional Benefit Extend of Orphan Drugs Impact Price Negotiations in the German Outpatient Sector?
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32828-5&doi=10.1016/j.jval.2016.09.1462
First page : A600
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1374
Categories :
Tags :
Regions :
ViH Article Tags :